{
  "ticker": "MDR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971442",
  "id": "02971442",
  "pages": 35,
  "price_sensitive": false,
  "date": "20250722",
  "time": "1105",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250722/pdf/06m0s0cwrlwcqv.pdf",
  "summary": "### **Material Information Summary \u2013 MedAdvisor Limited (ASX: MDR) EGM Notice**  \n\n#### **Key Resolutions for Shareholder Approval**  \n1. **Ratification of Prior Placement (Resolution 1)**  \n   - **Type**: Placement ratification under ASX Listing Rule 7.4.  \n   - **Details**: Ratifies prior issue of **45.75M shares** at **A$0.10/share** (total **A$4.575M**) to institutional/sophisticated investors.  \n   - **Use of Funds**: Working capital for strategic/cost initiatives (e.g., strategic review, sales team restructuring).  \n\n2. **Director Share Issuance (Resolutions 2A\u20132D)**  \n   - **Structure**: Placement shares to directors at same terms (A$0.10/share).  \n   - **Total**: **3.75M shares** (A$375K) to:  \n     - Richard Ratliff (750K shares),  \n     - Kate Hill (500K shares),  \n     - Kevin Hutchinson (2M shares),  \n     - Lucas Merrow (500K shares).  \n\n3. **Corporate Advisor Share Issuance (Resolution 3)**  \n   - **Issue**: **500K shares** at A$0.10/share to Adelaide Equity Partners (A$50K).  \n\n4. **Ratification of Lead Managers\u2019 Options (Resolution 4)**  \n   - **Details**: Ratifies prior issue of **5M unlisted options** to Canaccord/Peloton Capital (exercise price A$0.20, 3-year term).  \n\n5. **CEO Incentive Options (Resolution 5)**  \n   - **Issue**: **2,182,540 options** to CEO Richard Ratliff (nil exercise price, 10-year term).  \n\n6. **Retention Bonuses (Cash) (Resolutions 6A\u20136C)**  \n   - **Approval**: Termination benefits linked to potential ANZ/US business sales:  \n     - Richard Ratliff: **USD 275K**,  \n     - Ancila Desai: **AUD 225K**,  \n     - Vinod Subramanian: **USD 200K**.  \n\n7. **Retention Bonuses (Equity & Entitlements) (Resolutions 7A\u20137C)**  \n   - **Approval**: Additional benefits (severance, LTIP vesting):  \n     - Ratliff: **USD 554K** + 22.6M LTIP securities,  \n     - Desai: **AUD 112.5K** + 4.5M LTIP securities,  \n     - Subramanian: **USD 100K** + 4M LTIP securities.  \n\n#### **General Meeting Details**  \n- **Date/Time**: 21 August 2025, 11:00 AM AEST.  \n- **Format**: Virtual via [Computershare platform](https://meetnow.global/MJJASWC).  \n- **Record Date**: 19 August 2025 (7:00 PM AEST).  \n\n#### **Impact on Capital Structure**  \n- **Placement/Director Issuances**: Adds **50M new shares** (post-approval), diluting existing holders.  \n- **Voting Exclusions**: Applies to related parties (e.g., directors, advisors) per resolutions.  \n\n**Board Recommendations**:  \n- Supports all resolutions except director-related (abstained due to conflict).  \n\n**Next Steps**: Approval required for capital raises, incentive plans, and retention payments.",
  "usage": {
    "prompt_tokens": 23716,
    "completion_tokens": 753,
    "total_tokens": 24469,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-22T01:47:41.558461"
}